£110.00

It has never been this cheap. We have no record of a lower price.

£110 today · cheaper than every other day in the last 3 months

Elsevier Advances in Cancer Research (Volume 72)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 81 days · 81 data points (no recent data)

Historical
Generating forecast…
£110.00 £104.50 £106.70 £108.90 £111.10 £113.30 £115.50 11 August 2026 31 August 2026 20 September 2026 10 October 2026 30 October 2026
View at Amazon ↗

Price data last checked 10 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 81 days • 1 price levels

Days at Price
81 days 0 20 41 61 81 £110 Days at Price

Price Analysis

Most common price: £110 (81 days, 100.0%)

Price range: £110 - £110

Price levels: 1 different prices over 81 days

Description

The presentation of Foundations in Cancer Research articles has become a focal point of the Advances in Cancer Research series. This volume begins with two such timely reviews, the first of which is by series co-editor George Klein. Dr. Klein evaluates and reviews Leslie Foulds' suggestion that tumors develop in a series of steps and the effect that this 40-year-old hypothesis has had on cancer research. The second Foundations article by L.A. Loeb presents the historical significance of increased mutagenesis and clonal selection on tumor progression. The first regular article, by R. Khosravi-Far and colleagues, analyzes the functional role of Ras in signal transduction and the involvement that Rho family proteins have on Ras. Mark Saville and Roger Watson review supporting evidence that B-Myb may be a critical regulator of the cell cycle. S. Baylin and co-authors compare DNA methylation in normal cells with that in cancerous cells and discuss the specific consequences associated with tumor progression. Last, Steven Grant discusses the use of ara-C as a treatment for various types of cancer and summarizes its cellular metabolism, mode of action and resistance, and the molecular events involved in apoptosis.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
13 February 1998
Listed Since
25 September 2005

Barcode

No barcode data available

Similar Products You Might Like

Advances in Cancer Research: 103: Volume 103
81% match

Advances in Cancer Research: 103: Volume 103

Elsevier

£69.09 30 Aug 2026
Advances in Cancer Stem Cell Biology
81% match

Advances in Cancer Stem Cell Biology

Springer

£112.48 24 Oct 2026
Gene Regulation and Therapeutics for Cancer
81% match

Gene Regulation and Therapeutics for Cancer

CRC Press

£72.24 21 Oct 2026
Advances in Cancer Research Volume 72
80% match

Advances in Cancer Research Volume 72

Academic Press

£110.00 24 Oct 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
80% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.67 22 Oct 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
80% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£78.01 21 Oct 2026
Advances in Cancer Stem Cell Biology
80% match

Advances in Cancer Stem Cell Biology

Springer

£95.45 02 Sep 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
79% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.14 24 Oct 2026
Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)
79% match

Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)

Springer

£113.76 22 Oct 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
79% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 22 Oct 2026
The Rho GTPases in Cancer
79% match

The Rho GTPases in Cancer

Springer

£110.08 25 Oct 2026
Advances in Molecular Oncology: 604 (Advances in Experimental Medicine and Biology, 604)
79% match

Advances in Molecular Oncology: 604 (Advances in Experimental Medicine and Biology, 604)

Springer

£142.41 23 Oct 2026
Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs: Cell Signaling Pathways and microRNAs in Cancer Biology
79% match

Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs: Cell Signaling Pathways and microRNAs in Cancer Biology

Springer

£107.85 15 Oct 2026
Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
79% match

Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology

Springer

£113.03 15 Oct 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
79% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 23 Oct 2026
Cancer Genes and their Clinical Implications, Part B (Volume 1) (Current Perspectives on Molecular and Cellular Oncology, Volume 1)
79% match

Cancer Genes and their Clinical Implications, Part B (Volume 1) (Current Perspectives on Molecular and Cellular Oncology, Volume 1)

Elsevier

£65.99 31 Aug 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
78% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£75.96 26 Oct 2026
Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)
78% match

Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)

Springer

£113.76 22 Oct 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
78% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 24 Oct 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
78% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£161.26 24 Oct 2026
Stem Cells in Cancer: Should We Believe or Not?
78% match

Stem Cells in Cancer: Should We Believe or Not?

Springer

£110.18 30 Oct 2026
Advances in Brain Tumor Therapy: From Molecular Mechanisms to Clinical Practice
78% match

Advances in Brain Tumor Therapy: From Molecular Mechanisms to Clinical Practice

Elsevier

£137.99 23 Oct 2026
Cell Signaling & Molecular Targets in Cancer
78% match

Cell Signaling & Molecular Targets in Cancer

Springer

£109.62 20 Oct 2026
Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)
78% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Elsevier

£153.99 22 Oct 2026